Drug Shortage Report for GD-DICLOFENAC/MISOPROSTOL 50

Last updated on 2020-04-24 History
Report ID 109116
Drug Identification Number 02341689
Brand name GD-DICLOFENAC/MISOPROSTOL 50
Common or Proper name GD-DICLO/MISO 50
Company Name GENMED A DIVISION OF PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) MISOPROSTOL DICLOFENAC SODIUM
Strength(s) 200MCG 50MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 250's
ATC code M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-03-19
Estimated end date 2020-12-30
Actual end date 2020-04-23
Shortage status Resolved
Updated date 2020-04-24
Company comments Current available inventory and scheduled deliveries will be preventatively managed through local allocation until approximately end of December 2020. Other presentation available: Arthrotec 50mg
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-04-24 English Compare
v4 2020-04-23 French Compare
v3 2020-04-23 English Compare
v2 2020-03-20 French Compare
v1 2020-03-20 English Compare

Showing 1 to 5 of 5